The anti-inflammatory natural product parthenolide from the medicinal herbFeverfew directly binds to and inhibits I kappa B kinase

Citation
Bhb. Kwok et al., The anti-inflammatory natural product parthenolide from the medicinal herbFeverfew directly binds to and inhibits I kappa B kinase, CHEM BIOL, 8(8), 2001, pp. 759-766
Citations number
38
Categorie Soggetti
Biochemistry & Biophysics
Journal title
CHEMISTRY & BIOLOGY
ISSN journal
10745521 → ACNP
Volume
8
Issue
8
Year of publication
2001
Pages
759 - 766
Database
ISI
SICI code
1074-5521(200108)8:8<759:TANPPF>2.0.ZU;2-L
Abstract
Background: Biologically active natural products continue to be useful in t he exploration and control of intracellular signaling processes. For exampl e, the sesquiterpene lactone parthenolide from the anti-inflammatory medici nal herb Feverfew (Tanacetum parthenium) appears to inhibit the pro-inflamm atory signaling pathway. Parthenolide's direct molecular target, however, r emains unknown. We set out to identify the molecular mechanisms of partheno lide's anti-inflammatory activity. Results: A parthenolide affinity reagent was synthesized and shown to bind directly to and inhibit I kappaB kinase beta (IKK beta) the kinase subunit known to play a critical role in cytokine-mediated signaling. Mutation of c ysteine 179 in the activation loop of IKK beta abolished sensitivity toward s parthenolide. Moreover, we showed that parthenolide's in vitro and in viv o anti-inflammatory activity is mediated through the alpha -methylene gamma -lactone moiety shared by other sesquiterpene lactones. Conclusions: In recent years, the multi-subunit IKK complex has been shown to be responsible for cytokine-mediated stimulation of genes involved in in flammation and as such represents an attractive target for pharmaceutical i ntervention. Our finding that parthenolide targets this kinase complex prov ides a possible molecular basis for the anti-inflammatory properties of par thenolide. In addition, these results may be useful in the development of a dditional anti-inflammatory agents. (C) 2001 Elsevier Science Ltd. All righ ts reserved.